These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1705463)

  • 1. Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid.
    Botez MI; Young SN
    Brain; 1991 Feb; 114 ( Pt 1A)():333-48. PubMed ID: 1705463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias.
    Botez MI; Young SN
    Can J Neurol Sci; 2001 May; 28(2):134-40. PubMed ID: 11383938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of biogenic amine levels in the Rett syndrome.
    Zoghbi HY; Percy AK; Glaze DG; Butler IJ; Riccardi VM
    N Engl J Med; 1985 Oct; 313(15):921-4. PubMed ID: 2412119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid and blood thiamine concentrations in phenytoin-treated epileptics.
    Botez MI; Joyal C; Maag U; Bachevalier J
    Can J Neurol Sci; 1982 Feb; 9(1):37-9. PubMed ID: 7093823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate and monoamine metabolism in epilepsy.
    Reynolds EH; Chadwick D; Jenner P; Chanarin I
    J Neurol Sci; 1975 Dec; 26(4):605-15. PubMed ID: 1206436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid.
    Ormazabal A; Artuch R; Vilaseca MA; Aracil A; Pineda M
    Neuropediatrics; 2005 Dec; 36(6):380-5. PubMed ID: 16429378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
    Arai M
    Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects.
    Bertilsson L; Asberg M
    Adv Biochem Psychopharmacol; 1984; 39():27-34. PubMed ID: 6205559
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiamine deficiency and cerebrospinal fluid 5-hydroxyindoleacetic acid: a preliminary study.
    Botez MI; Young SN; Bachevalier J; Gauthier S
    J Neurol Neurosurg Psychiatry; 1982 Aug; 45(8):731-3. PubMed ID: 6182272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary abnormalities of neurotransmitters in infants with neurological disorders.
    García-Cazorla A; Serrano M; Pérez-Dueñas B; González V; Ormazábal A; Pineda M; Fernández-Alvarez E; Campistol JM; Artuch RM
    Dev Med Child Neurol; 2007 Oct; 49(10):740-4. PubMed ID: 17880642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
    Wode-Helgodt B; Sedvall G
    Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 18. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.